🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

RecruitingNAAges 18 Years - anyFemaleUniversiti Putra Malaysia
NCT06815250 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The main questions it aims to answer are: Does the InTroDuce-Programme increase knowledge and future intention of pregnant mothers to get vaccinated against Influenza and Tdap? How does demographic factors, attitudes and barriers affect vaccination decisions among pregnant mothers? Researchers will compare InTroDuce-Programme to standard care (routine antenatal care) to see if InTroDuce-Programme works to improve knowledge and future intention of pregnant mothers to be vaccinated against Influenza and Tdap. Participants will: Receive the web-based educational module (InTroDuce-Programme), which covers the importance, safety, and effectiven

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pregnant women aged 18 years and older * Before or equal to 32 weeks of gestation as we need to follow-up the patients again at 36 weeks of gestation before delivery occurs. * Able to understand and consent to participation in the study. Exclusion Criteria: * Pregnant women with severe anaphylactic or allergic reactions to previous dose of influenza or Tdap vaccination. * Non-Malaysian
💊

What it tests

  • Influenza and Tdap Vaccination Educational and Learning Module
📍

Where

4 sites
Klinik Kesihatan Bangi
Bandar Baru Bangi, Malaysia
Klinik Kesihatan Batu 9
Cheras, Malaysia
Klinik Kesihatan Balakong
Cheras, Malaysia
Klinik Kesihatan Kajang
Kajang, Malaysia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy